Novabay Pharmaceuticals Inc Цена / балансовая стоимость
Что обозначает Цена / балансовая стоимость в Novabay Pharmaceuticals Inc?
Цена / балансовая стоимость Novabay Pharmaceuticals Inc является 0.98
Какое определение для Цена / балансовая стоимость?
Отношение рыночной цены акции к её балансовой учётной стоимости представляет собой соотношение между стоимостью акций компании и балансовой стоимостью на акцию.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Цена / балансовая стоимость компаний в Health Care сектор на NYSEMKT по сравнению с Novabay Pharmaceuticals Inc
Что делает Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Компании с цена / балансовая стоимость похож на Novabay Pharmaceuticals Inc
- Kubota имеет Цена / балансовая стоимость из 0.98
- China Leasing имеет Цена / балансовая стоимость из 0.98
- Worldwide Healthcare Trust Plc имеет Цена / балансовая стоимость из 0.98
- Jaguar Health Inc имеет Цена / балансовая стоимость из 0.98
- Manulife Floating Rate Senior Loan Fund имеет Цена / балансовая стоимость из 0.98
- Broadstone Net Lease имеет Цена / балансовая стоимость из 0.98
- Novabay Pharmaceuticals Inc имеет Цена / балансовая стоимость из 0.98
- Cinevista имеет Цена / балансовая стоимость из 0.98
- Alpha & Omega Semiconductor Ltd имеет Цена / балансовая стоимость из 0.98
- abrdn Life Sciences Investors имеет Цена / балансовая стоимость из 0.98
- Nile имеет Цена / балансовая стоимость из 0.98
- Bénéteau SA имеет Цена / балансовая стоимость из 0.98
- Green Brick Partners имеет Цена / балансовая стоимость из 0.98